The applicants have constructed a hybrid transgene in which SV40 large T-antigen (Tag) expression was directed by the tartrate-resistant acid phosphatase (TRAP) gene promoter to target Tag to the osteoclast (OCL) in transgenic mice, as a means of developing OCL cell lines. They produced five transgenic TRAP-Tag founder mice that had Tag targeted to the OCL. Transgenic lines then were produced from two of these founder mice. All of these mice had increased OCL, transformed OCL, OCL with mitotic figures and hyperploidy, demonstrating the feasibility of this approach. Several TRAP-Tag animals developed OCL tumors in their marrow and three primary cell cultures were isolated that formed OCL, suggesting that OCL cell lines can be produced from these animals. However, permanent cell lines have not as yet been established, possibly reflecting that additional transforming genes are needed to immortalize OCL. In this application, these previous studies will be extended to (1) establish mice transgenic for bcl-xL, fused to the TRAP promoter (TRAP-bcl-xL), interbreed these mice with TRAP-Tag mice to make mice doubly transgenic for Tag and bcl-xL targeted to the OCL, and continue to further characterize the TRAP-Tag transgenic mice, and attempt to develop and characterize OCL cell lines from these mice; (2) clone the promoter for collagenase Type IV (Col4B), a gene expressed very early in the OCL lineage, characterize the Col4B promoter activity, and confirm by in situ hybridization that levels of Col4B mRNA are markedly increased in OCL versus other bone cells; (3) produce transgenic TRAP-myc and Col4B- ras mice to determine their capacities to develop OCL tumors, characterize these tumors and determine if cell lines can be derived from these tumors, crossbreed TRAP-myc to Col4B-ras or TRAP-Tag or TRAP-bcl- xL mice to produce doubly transgenic mice; and (4) determine the effects of osteotropic factors on OCL cell lines derived from these transgenic mice.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR041336-08
Application #
2769588
Study Section
Orthopedics and Musculoskeletal Study Section (ORTH)
Project Start
1991-09-30
Project End
1999-08-31
Budget Start
1998-09-01
Budget End
1999-08-31
Support Year
8
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Texas Health Science Center San Antonio
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
800772162
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Ishizuka, Hisako; García-Palacios, Verónica; Lu, Ganwei et al. (2011) ADAM8 enhances osteoclast precursor fusion and osteoclast formation in vitro and in vivo. J Bone Miner Res 26:169-81
Tondelli, Barbara; Blair, Harry C; Guerrini, Matteo et al. (2009) Fetal liver cells transplanted in utero rescue the osteopetrotic phenotype in the oc/oc mouse. Am J Pathol 174:727-35
Garcia-Palacios, Veronica; Chung, Ho Yeon; Choi, Sun Jin et al. (2007) Eosinophil chemotactic factor-L (ECF-L) enhances osteoclast formation by increasing in osteoclast precursors expression of LFA-1 and ICAM-1. Bone 40:316-22
Palacios, Veronica Garcia; Chung, Ho Yeon; Choi, Sun Jin et al. (2006) Eosinophil chemotactic factor-L (ECF-L) enhances osteoclast formation by increasing ICAM-1 expression. Ann N Y Acad Sci 1068:240-3
Lu, Ganwei; Maeda, Hidefumi; Reddy, Sakamuri V et al. (2006) Cloning and characterization of the annexin II receptor on human marrow stromal cells. J Biol Chem 281:30542-50
Rao, Hongwei; Lu, Ganwei; Kajiya, Hiroshi et al. (2006) Alpha9beta1: a novel osteoclast integrin that regulates osteoclast formation and function. J Bone Miner Res 21:1657-65
Xing, Lianping; Boyce, Brendan F (2005) Regulation of apoptosis in osteoclasts and osteoblastic cells. Biochem Biophys Res Commun 328:709-20
Roodman, G David (2004) Mechanisms of bone metastasis. N Engl J Med 350:1655-64
Oba, Yasuo; Chung, Ho Yeon; Choi, Sun Jin et al. (2003) Eosinophil chemotactic factor-L (ECF-L): a novel osteoclast stimulating factor. J Bone Miner Res 18:1332-41
Choi, S J; Oba, Y; Gazitt, Y et al. (2001) Antisense inhibition of macrophage inflammatory protein 1-alpha blocks bone destruction in a model of myeloma bone disease. J Clin Invest 108:1833-41

Showing the most recent 10 out of 38 publications